πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 10 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11124768

Optimally activated dendritic cells that induce an improved or increased anti-tumor immune

Northwest Biotherapeutics, Inc. Β· Granted Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9566294

Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigene

Northwest Biotherapeutics, Inc. Β· Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8518636

Tangential flow filtration devices and methods for leukocyte enrichment

Northwest Biotherapeutics, Inc. Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8409566

Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigene

Northwest Biotherapeutics, Inc. Β· Granted Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790039

Tangential flow filtration devices and methods for stem cell enrichment

Northwest Biotherapeutics, Inc. Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7695627

Tangential flow filtration devices and methods for leukocyte enrichment

Northwest Biotherapeutics, Inc. Β· Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7087715

Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses

Northwest Biotherapeutics, Inc. Β· Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6936448

Nucleic acids and proteins of a rat ganglioside GM1-specific Ξ±1-2fucosyltransferase and us

Northwest Biotherapeutics, Inc. Β· Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6863887

Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigene

Northwest Biotherapeutics, Inc. Β· Granted Tue Mar 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6150508

Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane

Northwest Biotherapeutics, Inc. Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired